0-1, 2022, Analisi statistiche e metanalisi, Autore, Cancanelli, Chiumente, Di Spazio, Impact factor, Mengato, Messori, Pubblicazioni, Rivano, Topic
Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy
1-2, 2022, Analisi statistiche e metanalisi, Anno, Autore, Cancanelli, Chiumente, Di Spazio, Impact factor, Mengato, Messori, Pubblicazioni, Rivano, Topic
The Degree of Programmed Death-Ligand 1 (PD-L1) Positivity as a Determinant of Outcomes in Metastatic Triple-Negative Breast Cancer Treated With First-Line Immune Checkpoint Inhibitors.
1-2, 2021, Analisi statistiche e metanalisi, Anno, Autore, Cancanelli, Chiumente, Di Spazio, Impact factor, Mengato, Messori, Pubblicazioni, Rivano, Topic
Efficacy of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer: Analysis of Three Phase-II Trials.
1-2, 2021, Agnoletto, Anno, Autore, Cammalleri, Cancanelli, Chiumente, Costantino, Damuzzo, Impact factor, Mengato, Michielan, Milani, Pubblicazioni, Rampazzo, Rivano, Sartori, Studi real world, Topic